Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.

Peto L. et al, (2024), Lancet (London, England), 403, 1339 - 1340

‘Involve those, who are managing these outbreaks’– Identifying barriers and facilitators to the implementation of clinical management guidelines for High-Consequence Infectious Diseases in Uganda

Kabajaasi O. et al, (2024)

Mpox: The alarm went off. Have we gone back to sleep?

Olliaro P. et al, (2024), PLOS Neglected Tropical Diseases, 18, e0011871 - e0011871

Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity

Swets MC. et al, (2023), Nature Communications, 14

A multi-country analysis of COVID-19 hospitalizations by vaccination status.

Gonçalves BP. et al, (2023), Med (New York, N.Y.), 4, 797 - 812.e2

The burden and dynamics of hospital-acquired SARS-CoV-2 in England.

Cooper BS. et al, (2023), Nature

Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Pairo-Castineira E. et al, (2023), Nature, 619, E61 - E61

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.

Pairo-Castineira E. et al, (2023), Nature, 617, 764 - 768

Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.

Kayem ND. et al, (2023), PLoS neglected tropical diseases, 17

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2023)

Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.

Kayem ND. et al, (2023), PLoS Negl Trop Dis, 17

Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.

Siggins MK. et al, (2023), Immunology, 168, 473 - 492

Facilitating participation in clinical trials during pregnancy.

Vousden N. et al, (2023), BMJ, 380

Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs

Rigby I. et al, (2023), The Lancet Infectious Diseases

Randomised controlled trials for mpox in endemic countries.

Rojek A. et al, (2023), Lancet Infect Dis

MOSAIC: A cohort study of human mpox virus disease.

Pesonel E. et al, (2023), Wellcome open research, 8

MOSAIC: A cohort study of human mpox virus disease

Pesonel E. et al, (2023)

Natural immune boosting can cause synchrony in susceptibility and outbreaks of respiratory infections with rapidly waning immunity

Pritchard M. et al, (2023)

Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2022)

An evaluation of global Chikungunya clinical management guidelines: A systematic review

Webb E. et al, (2022), eClinicalMedicine, 54, 101672 - 101672

Tecovirimat for Monkeypox in Central African Republic under Expanded Access.

Mbrenga F. et al, (2022), The New England journal of medicine, 387, 2294 - 2295

Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

Rigby I. et al, (2022), BMC Medicine, 20

Human infection with a reassortment avian influenza A H3N8 virus: an epidemiological investigation study.

Bao P. et al, (2022), Nature communications, 13

Seroepidemiology of enterovirus A71 infection in prospective cohort studies of children in southern China, 2013-2018.

Yang J. et al, (2022), Nature communications, 13

Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients

Baruch J. et al, (2022), Influenza and Other Respiratory Viruses, 16, 1040 - 1050

An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.

Gonçalves BP. et al, (2022), eLife, 11

Evaluation of S/F94 as a proxy for COVID-19 severity

Swets MC. et al, (2022)

RapiD_AI: A framework for Rapidly Deployable AI for novel disease & pandemic preparedness

Youssef A. et al, (2022)

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2022)

A prototype lateral flow assay for detection of orthopoxviruses.

Ulaeto DO. et al, (2022), The Lancet. Infectious diseases, 22, 1279 - 1280

Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number

Keeling MJ. et al, (2022), Statistical Methods in Medical Research, 31, 1716 - 1737

Monkeypox treatment with tecovirimat in the Central African Republic under an Expanded Access Programme

Mbrenga F. et al, (2022)

Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort

Hoa LNM. et al, (2022), The Journal of Infectious Diseases, 226, 59 - 69

RapiD_AI: A framework for Rapidly Deployable AI for novel disease & pandemic preparedness

Youssef A. et al, (2022)

Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review

Webb E. et al, (2022), BMJ Global Health, 7, e009838 - e009838

Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19

Norris T. et al, (2022), Heart, 108, 1200 - 1208

Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies1.

Cheng H-Y. et al, (2022), Emerging infectious diseases, 28, 1559 - 1568

Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases.

Hassoun-Kheir N. et al, (2022), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Perspectives of patients, family members, health professionals and the public on the impact of COVID-19 on mental health.

Gardiner E. et al, (2022), Journal of mental health (Abingdon, England), 31, 524 - 533

Serological Evidence of Human Infection With Avian Influenza A(H7N9) Virus: A Systematic Review and Meta-analysis.

Wang W. et al, (2022), The Journal of infectious diseases, 226, 70 - 82

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

Abbas A. et al, (2022), Scientific Data, 9

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Abani O. et al, (2022), The Lancet, 400, 359 - 368

Establishing COVID-19 trials at scale and pace: Experience from the RECOVERY trial.

Peto L. et al, (2022), Advances in biological regulation

Whole-genome sequencing reveals host factors underlying critical COVID-19.

Kousathanas A. et al, (2022), Nature, 607, 97 - 103

Ebola virus disease in pregnancy: a systematic review and meta-analysis

Kayem ND. et al, (2022), Transactions of The Royal Society of Tropical Medicine and Hygiene, 116, 509 - 522

Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

Knight SR. et al, (2022), Thorax, 77, 606 - 615

Why preprints are good for patients

Horby P., (2022), Nature Medicine, 28, 1109 - 1109

Allocated but not treated: the silent 16%

Horby P. et al, (2022), LANCET, 399, 1776 - 1776

Allocated but not treated: the silent 16% – Authors' reply

Horby P. et al, (2022), The Lancet, 399, 1775 - 1776

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?